10 employees
Jenken Biosciences is a specialty dedicated to the development and commercialization of first-in-class small molecules as TLR4 antagonists.
2003
$143K
from 1 investors over 1 rounds
Jenken Biosciences, Inc. raised $143K on July 14, 2007
Investors: North Carolina Biotechnology Center (NCBiotech)